Wednesday, November 14, 2018

February / 2018

Misplaced spending. Foreign aid does not reduce migration

 
While Western governments invest billions of foreign aid dollars in programs aimed at reducing the flow of migrants into the United States and Europe, the evidence suggests that such efforts can be futile, and even counter-productive. Two researchers at Center for Global Development argue that a smarter approach would be to manage migration for the benefit of all sides, instead of trying to halt it.
Read more >>
 
 

International NGO brands lay claim to billions of dollars earmarked for local actors

 
In a fierce power struggle over emergency relief funds, Western NGOs have secured a loophole in the agreement on reforming the humanitarian system that would allow their own affiliates in developing countries to tap into some USD 5 billion earmarked for local NGOs.
Read more >>

Indian drug firm challenges GSK, Pfizer in race for multi-billion-dollar aid-financed vaccine market

 
The Indian pharmaceutical company Serum Institute says its pneumonia vaccine will be ready for sale in developing countries by 2020 at a fraction of the going price. This places Serum in direct competition with two Western drug manufacturers, GSK and Pfizer, which have dominated the aid- financed pneumonia vaccine market for the last decade.
Read more >>

Leading Sida in a time of increased isolation

 
Compared with a decade ago, the global outlook today is somewhat pessimistic, and Sweden has become more isolated. This is the reflection of Carin Jämtin, the new Director General of Sida. She left her post as Minister for International Development Cooperation in 2006 and now looks back on that time as a more hopeful period.
Read more >>

Donor earmarking of WFP funds makes it more difficult to reach forgotten crises

 
Increased donor earmarking of funds to WFP makes it more difficult for the world’s largest humanitarian agency to respond rapidly to crises that are outside the limelight of global politics. Funds that WFP can use freely have dropped from 12 to 6 per cent of its total budget over the last seven years.  
Read more >>

Pneumonia vaccine remains expensive after 10 years of Gavi’s AMC funding

 
When the innovative USD 1.5 billion financing mechanism, the AMC, was launched by Gavi ten years ago, it was expected to do two things: accelerate the distribution of pneumonia vaccine among children in poor countries and incentivise more suppliers to enter the market, thereby increasing competition and pushing prices down. The AMC succeeded on the first but failed on the second.
Read more >>

Danish aid targets return of 1,000 rejected asylum seekers

 
Denmark is for the first time directly linking development funds with the return of migrants whose applications for asylum have been turned down. So far DKK 50 million in aid have been allocated to facilitate the return from Denmark of 198 rejected asylum seekers to six countries, including Nigeria, Somalia and Afghanistan.
Read more >>

Norfund turned its back on Statkraft to focus on Africa

 
The Norwegian aid-financed investor Norfund expects to present a surplus of about NOK 2 billion for 2017, after taking full control of the hydropower investor SN Power last fall, a result of strong disagreement with the co-owner Statkraft about investments in Africa.
Read more >>